Overexpression of LAPTM4B-35 is associated with poor prognosis in colorectal carcinoma

American Journal of Surgery

Volumn 204, Issue 5, 2012, Pages 677-683

  Kang, Yue ^a   Yin, Mingzhu ^b   Jiang, Wei ^b   Zhang, Haiyu ^b   Xia, Bairong ^c   Xue, Yingwei ^b   Huang, Yuenan ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c JIAMUSI UNIVERSITY   (China)

Author keywords

Colorectal cancer; Immunohistochemistry; LAPTM4B; Survival; Western blot

Indexed keywords

ANTINEOPLASTIC AGENT; LYSOSOME ASSOCIATED PROTEIN TRANSMEMBRANE 4BETA; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL CARCINOMA; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONCOGENE PROTEINS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84868518483     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2012.02.003     Document Type: Article

References (25)

1. A. Jemal, R. Siegel, E. Ward Cancer statistics CA Cancer J Clin 2008 2008 71 96
2. O.M. Jones, S.K. John, N. Horseman Cause and place of death in patients dying with colorectal cancer Colorectal Dis 9 2007 253 257
3. M. Yamasaki, I. Takemasa, T. Komori The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer Int J Oncol 30 2007 129 138
4. E.R. Fearon, B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
5. B. Vogelstein, E.R. Fearon, S.R. Hamilton Genetic alterations during colorectal-tumor development N Engl J Med 319 1988 525 532
6. B. Carvalho, C. Postma, S. Mongera Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression Gut 58 2009 79 89
7. X.R. Liu, R.L. Zhou, Q.Y. Zhang Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma World J Gastroenterol 10 2004 1555 1559
8. G.Z. Shao, R.L. Zhou, Q.Y. Zhang Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma Oncogene 22 2003 5060 5069
9. J.J. Liu, R.L. Zhou, N. Zhang Biological function of a novel gene over expressed in human hepatocellular carcinoma Chin Med J (Engl) 113 2000 881 885
10. G. Kasper, A. Vogel, I. Klaman The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression Cancer Lett 224 2005 93 103
11. M. Yin, C. Li, X. Li Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer J Surg Oncol 104 2011 29 36
12. M. Yin, Y. Xu, G. Lou LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis Int J Cancer 129 2011 629 635
13. C. Peng, R.L. Zhou, G.Z. Shao Expression of lysosomeassociated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma World. Gastroenterologist 11 2005 2704 2708
14. H. Yang, F.X. Xiong, M. Lin LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma J Cancer Res Clin Oncol 136 2010 275 281
15. H. Yang, F. Xiong, R. Qi LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma J Surg Oncol 101 2010 363 369
16. L. Zhou, L. Zhou, X.D. He Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma Eur J Cancer 4 2007 809 815
17. L. Zhou, X.D. He, Q.C. Cui Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma Cancer Lett 2 2008 209 217
18. Y. Yang, H. Yang, M.A. McNutt LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma Oncol Rep 20 2008 1077 1083
19. F.L. Meng, M.Z. Yin, H.T. Song LAPTM4B-35 overexpression is an independent prognostic marker in endometrial carcinoma Int J Gynecol Cancer 20 2010 745 750
20. Y. Li, L. Zou, Q. Li Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer Nat Med 16 2010 214 218
21. O. Fluge, K. Gravdal, E. Carlsen Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis Br J Cancer 101 2009 1282 1289
22. Y.L. Ma, J.Y. Peng, P. Zhang Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer Med Oncol 27 2010 304 309
23. X. Liu, R. Zhou, Q. Zhang Identification and characterization of LAPTM4B encoded by a human hepatocellular carcinoma-associated novel gene[in Chinese] Beijing Da Xue Xue Bao 35 2003 340 347
24. H. Yang, F. Xiong, X. Wei Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo Cancer Lett 294 2010 236 244
25. Y. Li, Q. Zhang, R. Tian Lysosomal transmembrane protein LAPTM4B Promotes autophagy and tolerance to metabolic stress in cancer cells Cancer Res 71 2011 7481 7489